unmet needs in ovarian cancer
Published 6 years ago • 199 plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
1:09
dr. arend on unmet needs in platinum-resistant ovarian cancer
-
2:19
dr. sehouli discusses unmet needs in ovarian cancer
-
1:57
dr. markman on unmet needs in rare gynecologic cancers
-
6:20
parp inhibitors in recurrent ovarian cancer
-
2:10
dr. markman on unmet needs in endometrial and cervical cancers
-
1:05
areas of unmet need for patients with ovarian cancer
-
1:15
dr. leath discusses unmet need in cervical cancer
-
1:41
dr. makker on unmet needs for patients with advanced endometrial cancer
-
1:12
optimal testing methods in ovarian cancer
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer
-
1:38
dr. chase on niraparib as frontline maintenance therapy in ovarian cancer
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer
-
5:28
unmet needs for metastatic breast cancer
-
1:12
dr. emens on immune-related adverse events in ovarian cancer
-
8:29
emerging combinations in the frontline setting of ovarian cancer
-
0:58
dr. cohen on the evolution of surgery in ovarian cancer
-
3:21
need for frontline comparison trials in ovarian cancer
-
1:37
dr. hays on immunotherapy in ovarian cancer treatment
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer